Press Releases

Date	Title
01/09/12	Summary Toggle Akebia Draws Down $4.1 Million Series B Financing Tranche
11/21/11	Summary Toggle Akebia Initiates Phase 1 Study of First-In-Class HPTPÎ² Inhibitor for Diabetic Macular Edema
11/15/11	Summary Toggle Akebia Therapeutics Announces Presentation of Clinical Data at Kidney Week 2011
06/23/11	Summary Toggle Akebia Announces Initiation of Phase 2a Dose Range Finding Study of AKB-6548 for Anemia
05/03/11	Summary Toggle Akebia Announces Successful Completion of Phase 2a Pilot Study of AKB-6548 For Anemia
04/26/11	Summary Toggle Akebia Completes $22M Series B Financing
10/05/10	Summary Toggle Akebia Announces Positive Results for AKB-6548 Phase 2a Clinical Study
07/22/10	Summary Toggle Akebia Announces Initiation of Phase 2a Clinical Study of AKB-6548
06/16/10	Summary Toggle Akebia Announces Positive Results for AKB-6548 Phase 1b Clinical Study and Completes $5M Second Tranche Series A Financing
04/06/10	Summary Toggle Akebia to Participate in the Future Leaders in the Biotech Industry Conference